Skip to main content

Peer Review reports

From: Objective disease activity assessment and therapeutic drug monitoring prior to biologic therapy changes in routine inflammatory bowel disease clinical practice: TARGET-IBD

Original Submission
26 Sep 2021 Submitted Original manuscript
9 Nov 2021 Reviewed Reviewer Report
9 Dec 2021 Reviewed Reviewer Report - Askin Erdogan
18 Jan 2022 Author responded Author comments - Benjamin Click
Resubmission - Version 2
18 Jan 2022 Submitted Manuscript version 2
2 Feb 2022 Author responded Author comments - Benjamin Click
Resubmission - Version 3
2 Feb 2022 Submitted Manuscript version 3
Publishing
6 Feb 2022 Editorially accepted
19 Feb 2022 Article published 10.1186/s12876-022-02143-x

You can find further information about peer review here.

Back to article page